3
2
1

A "Head-to-Head" Scientific Comparative Study: YF Cryoprotectant Self-Developed by Yinfeng Life Science Research Institute Demonstrates Significantly Superior Safety and Ice Inhibition Efficacy

2026/09/09

This head‑to‑head comparative study, backed by solid and transparent data, unequivocally demonstrates that China‑developed cryoprotectants already possess significant international competitiveness in core performance. This not only reflects Yinfeng's technological prowess but also serves as a compelling testament to China's cryobiomedicine field transitioning from "following" to "running alongside" global leaders—earning international discourse power through scientific evidence.

Breakthrough Organ Preservation Technology: Achieving Long-Term and Safe Preservation of Cells and Organs

2026/05/18

Beyond organ transplantation, this non-toxic low-temperature preservation framework can be extended to long-term storage of stem cells, reproductive cells, and germplasm resources of endangered species, providing a universal technological foundation for biobanks, regenerative medicine, and other fields.

Breaking the Cryopreservation Bottleneck: New Pretreatment Technique Boosts NK Cell Recovery Rate to 90%–100% After Thawing

2026/04/29

The clinical value of this approach lies in its extremely simple operation. It requires no specialized cryopreservation solutions or complex equipment, using only GMP‑grade compliant cytokines that can be removed by routine washing after pretreatment, posing no additional safety risks to patients and enabling rapid integration into existing cell production and cryopreservation workflows. As the large‑scale manufacturing of NK cells derived from umbilical cord blood and iPSCs becomes increasingly mature, combining this cryopreservation technology holds the potential to significantly reduce cell therapy costs and improve accessibility, opening new avenues for immunotherapy in hematological malignancies and solid tumors.

Scientists Achieve Functional "Revival" of Mouse Brain Tissue After Rewarming from -196°C Freezing First Successful Revival of Frozen Brain! Mouse brain tissue regains memory function after being frozen at -196°C and rewarmed

2026/03/16

In science fiction, human cryopreservation and resuscitation are often regarded as a "time capsule" to the future. Now, this concept has achieved a milestone breakthrough in the laboratory—scientists have for the first time successfully cryopreserved adult mouse brain slices in liquid nitrogen at -196°C and restored multiple key neural functions, including learning and memory mechanisms, after rewarming. This achievement blazes a brand-new trail for basic neuroscience research and organ preservation technology.

Good News! Three Organoid Cryopreservation Technologies of Our Team Accepted for National Patents

2025/08/15

In the era of rapid development of organoid research, achieving long - term stable preservation while maintaining biological activity and functional integrity remains a crucial bottleneck restricting the clinical translation of this technology and its application in drug R & D. Recently, three technological inventions by the research team of Yinfeng Low - Temperature Medical Research Center were accepted by the National Intellectual Property Administration. These three technologies focus on the challenges of organoid cryopreservation and cover the key steps in the entire process of organoid vitrification preservation, offering a more efficient and reliable solution for safeguarding biological samples in organoid research.

The World's First In - Vitro Dual Activation Technology for Primitive Follicles: A Baby Born after Intra - operative Ovarian Tissue Freeze - Thaw Transplantation

2025/07/03

On June 25, 2025, the team led by Professor Wang Huiying and Dr. Jin Bo from Shenzhen Hospital of Beijing University of Chinese Medicine collaborated with Shandong Yinfeng Life Science Research Institute to develop the "ovarian dual activation" technology. Through this technology, patients with POI (primary ovarian insufficiency) underwent intra - operative freeze - thaw activation of ovarian tissue. After intra - operative transplantation, a baby was born, and both the mother and the baby are healthy and safe.

2025-02-07

Bountiful Harvest: A Review of Life Extension Plan Scientific Achievements

With the rapid development of science and technology, humanity's exploration of life has never ceased. During the 2023-2024 period, we witnessed a series of exciting scientific achievements. These not only made significant progress in fields such as anti-aging, gene editing, organ regeneration, and immunotherapy but also pointed the way for future medical research.

2025-02-07

The 2024 World's Top Ten Scientific and Technological Advances Announced, with Significant Achievements in Life Sciences

Recently, the "2024 China/World Top Ten Scientific and Technological Advances" organized by the Chinese Academy of Sciences and the Chinese Academy of Engineering was unveiled. In the list of the world's top ten scientific advancements, breakthroughs in cell and gene technologies stood out, including the first 3D-printed functional human brain tissue, CAR-T therapy, gene editing, Google's new quantum chip, super microscope, and more.

2025-01-15

Milestone! World's First Ovarian Dual Activation Technology Assists Patients in Conception

ecently, a major breakthrough in the field of reproductive health has garnered wide attention. The "ovarian dual activation" technology, collaboratively developed by the Yinfeng Life Sciences Research Institute (referred to as "Yinfeng Life Sciences") and the team of Professor Wang Huiying and Dr. Jin Bo from the Shenzhen Hospital of Beijing University of Chinese Medicine (referred to as "the hospital"), has achieved another milestone in cryobiomedical technology. Using methods of "cryopreservation + PFC", this technology has helped two patients achieve natural conception, providing new hope for women of childbearing age who are cancer patients, infertile, or of advanced maternal age.

2025-01-13

Latest Breakthrough in Xenotransplantation: World's Third Genetically Edited Pig Kidney Transplanted into Human

Robert Montgomery, the director of the NYU Langone Transplant Institute, stated in an interview, "This gives us more insight into the expectations for clinical trials, which can include patients with relatively good overall health."

< 1...91011...17 >